Early Development: Accelerating Molecules Through To Proof-Of-Concept

Simplify early development and accelerate to Proof-of Concept

Proof-of-Concept (POC) is a key milestone in the development of a new drug candidate. At Quotient Sciences, we understand the increasing pressures on R&D budgets, therefore the need to transition molecules through early development to POC needs to be fast and cost-effective.

With fully integrated capabilities from First-in-Human testing to seamless drug product supply for patient trials, we simplify early development and accelerate molecules through to POC. Unparalleled in the pharmaceutical industry, our Integrated Programs get molecules to patients faster by dramatically shortening development timelines.

The difference Quotient delivers

Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials. This integration, enabled by Translational Pharmaceutics^®, provides the fastest route to POC, shortening the drug development timeline by up to 18 months, saving valuable resources and budget.